Torrent Pharmaceuticals reports consolidated net loss of Rs 152 crore in Q4
21st May 2019

Torrent Pharmaceuticals has reported results for the fourth quarter and year ended March 31, 2019. 

The company has reported a fall of 25.45% in its net profit at Rs 164 crore for the quarter ended March 31, 2019 as compared to Rs 220 crore for the same quarter in the previous year. However, total income of the company increased by 14.53% at Rs 1,584 crore for quarter under review as compared to Rs 1,383 crore for the quarter ended March 31, 2018.

On consolidated basis, the company has reported a net loss of Rs 152 crore for the quarter ended March 31, 2019 against net profit of Rs 228 crore for the corresponding quarter in the FY18. However, total consolidated income of the company rose by 7.03% at Rs 1,873 crore for quarter under review as compared to Rs 1,750 crore for the same quarter ended previous year.

For the year ended March 31, 2019, the company has posted a rise of 54.56% in its net profit at Rs 745 crore as compared to Rs 482 crore for the previous year. Total income of company increased 34.27% at Rs 6,144 crore for year under review as compared to Rs 4,576 crore for year ended March 31, 2018.

For the year ended March 31, 2019, on the consolidated basis, the company has posted fall of 35.69% in its net profit at Rs 436 crore as compared to Rs 678 crore for the previous year. However, total income of company increased by 23.70% at Rs 7,730 crore for year under review as compared to Rs 6,249 crore for year ended March 31, 2018.